Note 7 - RELATED PARTY TRANSACTIONS (Details) - USD ($) |
12 Months Ended | |
|---|---|---|
Mar. 31, 2016 |
Mar. 31, 2015 |
|
| Note 7 - Related Party Transactions Details | ||
| Balance due (to) Pharma and NDM at beginning of period | $ 192,505 | $ 0 |
| Amounts advanced to Pharma | 58,197 | 567,633 |
| Amounts received from Pharma | (228,361) | (7,692) |
| Reduction in prepayments to Pharma for clinical trials | (247,596) | (257,441) |
| Amount invoiced by Pharma to DDL and TCL | (331,714) | (106,193) |
| Amounts invoiced by DDL to Pharma | (16,307) | 0 |
| Expenses paid by Pharma on behalf of DDL and TCL | 0 | 134 |
| Intellectual property costs paid by Pharma on behalf of DDL and TCL | 0 | (946) |
| Sale of fixed and intangible assts to Pharma and NDM | 17,775 | 0 |
| Foreign exchange differences | 28,763 | (2,988) |
| Net balance due from Pharma and NDM at end of the period | $ (494,112) | $ 192,505 |